Khan, Mohammad Imran <br/><br/>
AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  02 2019 
 - 356-363 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-18-0141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Animals<br/>Cell Line, Tumor<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Knockout Techniques<br/>Humans<br/>Jumonji Domain-Containing Histone Demethylases--genetics<br/>Male<br/>Methylation--drug effects<br/>Mice<br/>MicroRNAs--genetics<br/>Nuclear Proteins--genetics<br/>PTEN Phosphohydrolase--genetics<br/>Phosphorylcholine--administration & dosage<br/>Prostatic Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Repressor Proteins--genetics<br/>Xenograft Model Antitumor Assays